TheEdgeResearch
Home / Stocks / OMRX

Orthometrix, Inc. (OMRX)

OTC Healthcare Medical - Specialties
$0.00 ▲ +0.00%
Market Cap
$4,699
Sector
Healthcare
Industry
Medical - Specialties
Beta
0.00
52-Wk Range
0.000001-0.0001
CEO
Reynald G. Bonmati
Country
US
Currency
USD

Orthometrix, Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Naples, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $4,699. On trailing twelve-month figures it carries a trailing P/E of 0.01, a net margin of 27.2%. Its beta of 0.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
0.01
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
0.71
Gross margin
69.6%
Operating margin
17.2%
Net margin
27.2%
Return on equity
Debt / equity
-0.22
Current ratio
5.35
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
7
IPO date
1995-08-02
Headquarters
Naples, FL, US
About Orthometrix, Inc.

Orthometrix, Inc., founded in 1993 and based in Naples, Florida, specializes in developing and distributing advanced technologies, methods, and devices aimed at enhancing musculoskeletal mobility. The company also focuses on providing non-invasive solutions to manage pain linked to conditions like osteoarthritis, plantar fasciitis, and other musculoskeletal issues that impede movement. Their product line encompasses a variety of offerings: Peripheral quantitative computed tomography (pQCT) systems, used for detailed bone and muscle measurement in both clinical and research environments. Patented motorized exercise systems, featuring unique vibration technology, designed for rehabilitation, physical therapy, and sports medicine applications. These are marketed to professional sports teams, fitness facilities, and the wellness-conscious public. Human performance measurement systems, which help track improvements in power and overall mobility. Extracorporeal shock wave therapy (ESWT) systems, offering non-invasive treatment for plantar fasciitis discomfort. Orthometrix provides sales and servicing for its range of products, which fall into categories such as bone and muscle diagnostics, research equipment, rehabilitation/physical therapy tools, sports and fitness gear, and home-use products. They serve a broad client base across the healthcare, veterinary, and sports & fitness sectors, both domestically in the United States and internationally. The company was previously known as Norland Medical Systems, Inc. before officially changing its name to Orthometrix, Inc. in April 2002.

Comparable companies

Orthometrix, Inc. is most often compared with the following Healthcare names:

ACBMARYXAXMPHDVYIBXGIGRWNSPDFNUNZQEBRSXHHF
More research on OMRX
OMRX technical analysis OMRX TheEdge Score Compare against peers
Open full interactive analysis & DCF →